Graphite Bio Stock Total Asset

GRPHDelisted Stock  USD 2.67  0.05  1.84%   
Graphite Bio fundamentals help investors to digest information that contributes to Graphite Bio's financial success or failures. It also enables traders to predict the movement of Graphite Stock. The fundamental analysis module provides a way to measure Graphite Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Graphite Bio stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Graphite Bio Company Total Asset Analysis

Graphite Bio's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

 = 

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current Graphite Bio Total Asset

    
  188.46 M  
Most of Graphite Bio's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Graphite Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition

Based on the latest financial disclosure, Graphite Bio has a Total Asset of 188.46 M. This is 97.49% lower than that of the Biotechnology sector and 90.46% lower than that of the Health Care industry. The total asset for all United States stocks is 99.36% higher than that of the company.

Graphite Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Graphite Bio's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Graphite Bio could also be used in its relative valuation, which is a method of valuing Graphite Bio by comparing valuation metrics of similar companies.
Graphite Bio is currently under evaluation in total asset category among its peers.

Graphite Fundamentals

About Graphite Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Graphite Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Graphite Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Graphite Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Graphite Stock

If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities